Skip to main content
Adam Olszewski, MD, Oncology, Providence, RI, Rhode Island Hospital

AdamJanOlszewskiMD

Oncology • Providence, RI

Hematologic Oncology

Associate Professor, Alpert Medical School of Brown University

Join to view full profile

Dr. Olszewski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Olszewski's full profile

Already have an account?

Summary

  • Dr. Olszewski is a triple-board certified (Hematology, Oncology, Medicine) hematologic-oncologist specializing in treatment of Hodgkin and non-Hodgkin lymphoma.

Education & Training

  • Icahn School of Medicine at Mount Sinai/St Luke’s-Roosevelt Hospital Center
    Icahn School of Medicine at Mount Sinai/St Luke’s-Roosevelt Hospital CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2000 - 2003
  • Medical University of Warsaw
    Medical University of WarsawClass of 1999

Certifications & Licensure

  • RI State Medical License
    RI State Medical License 2005 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
    Adam J Olszewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Evaluating the Incidence of Cardiovascular and Thrombotic Events in Secondary Polycythemia
    Adam J Olszewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Billed Palliative Care Services and End-of-Life Care in Patients with Hematologic Malignancies
    Adam J Olszewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Tumor-Specific Cell-Free DNA (cfDNA) in the Cerebrospinal Fluid (CSF) Detects Cytologically Occult Central Nervous System (CNS) Involvement in Aggressive Lymphomas 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Bendamustine-Rituximab Does Not Improve Survival over Rituximab Monotherapy for Older Patients with Nodal or Splenic Marginal Zone Lymphoma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Loss of Abelson Interactor-1 Is Linked to Inflammatory Hematopoiesis and Accelerated Aging of Hematopoietic System 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Mengyang Di and Adam Olszewski on Risk Assessment for Older DLBCL Patients
    Mengyang Di and Adam Olszewski on Risk Assessment for Older DLBCL PatientsFebruary 22nd, 2022
  • Dr Adam Olszewski on Research Still Needed on Palliative Care Services in Blood Cancers
    Dr Adam Olszewski on Research Still Needed on Palliative Care Services in Blood CancersMarch 3rd, 2020
  • Dr Adam Olszewski: Early Palliative Care Is Important and Beneficial for Patients with Blood Cancers
    Dr Adam Olszewski: Early Palliative Care Is Important and Beneficial for Patients with Blood CancersFebruary 15th, 2020
  • Join now to see all

Grant Support

  • Research ScholarAmerican Cancer Society2016–2019
  • Research ScholarAmerican Society of Hematology2015–2017
  • Medical Research GrantRhode Island Foundation2015–2016

Professional Memberships

Other Languages

  • Polish, Spanish, French, Russian

Hospital Affiliations

Dr. Adam Olszewski, Dr. Adam Olszewski, MD, Dr. A Olszewski, Dr. Adam Jan Olszewski